We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 1,162 results
  1. In Vitro Culturing of Human Trophoblasts from Term Placenta

    Since the early 1960s, researchers began culturing placental cells to establish an in vitro model to study the biology of human trophoblasts,...
    Lorenza Díaz, Andrea Olmos-Ortiz, ... Verónica Zaga-Clavellina in Maternal Placental Interface
    Protocol 2024
  2. Isolation of total DNA from Placenta Samples, both Fresh and following Formalin and Paraffin Treatment

    The isolation of DNA from placental tissue suspected of infection is an important tool for identifying microorganisms such as bacteria, fungi, and...
    Oscar Villavicencio-Carrisoza, Carlos Daniel Mora-Vargas, ... Addy Cecilia Helguera-Repetto in Maternal Placental Interface
    Protocol 2024
  3. Obtaining Tissues of Human Amniotic Membrane and Identification of Pluripotent Markers

    The immunofluorescence technique has been used to identify pluripotent markers in the human amniotic epithelial cells (hAEC). hAEC belonging to human...
    Sayra Cecilia Martínez-Herrera, Axel Castro-Abrego, ... Guadalupe García-López in Maternal Placental Interface
    Protocol 2024
  4. Evaluation of Leukocyte Chemotaxis Induced by Human Fetal Membranes in an In Vitro Model

    Leukocyte infiltration into the maternal-fetal interface is a consequence of the robust inflammation in the gestational tissues during term labor and...
    Pilar Flores-Espinosa, Ismael Mancilla-Herrera, ... Verónica Zaga-Clavellina in Maternal Placental Interface
    Protocol 2024
  5. Immunophenoty** of Leukocytes in Amniotic Fluid

    Immunophenoty** allows for the deep characterization of leukocytes present in biological samples. Here, we describe a complete procedure for the...
    Yi Xu, Derek Miller, ... Nardhy Gomez-Lopez in Maternal Placental Interface
    Protocol 2024
  6. Placental Trophoblast Cell Isolation from the Term Placenta

    Multiple cell lines have been utilized over time in studying placental biology. Still, most of them rely on choriocarcinoma cells or immortalized...
    Manuel Vidal Jr. S, Radnaa Enkhtuya, ... Ramkumar Menon in Maternal Placental Interface
    Protocol 2024
  7. Alzheimer’s Disease Prevention and Treatment Based on Population-Based Approaches

    The development of effective prevention and treatment strategies for Alzheimer’s disease (AD) and dementia is hindered by limited knowledge of the...
    Protocol 2024
  8. CSF N-Glycomics Using MALDI MS Techniques

    In this chapter, we will present the methodology currently applied in our laboratory for the structural elucidation of the cerebrospinal fluid (CSF)...
    Angela Messina, Donata Agata Romeo, ... Domenico Garozzo in Biomarkers for Alzheimer’s Disease Drug Development
    Protocol 2024
  9. CSF N-Glycomics Using High-Throughput UPLC-ESI Techniques in Alzheimer’s Disease

    In this chapter, we will present a high-throughput method applied in our laboratory for the structural elucidation of the cerebrospinal fluid (CSF)...
    Angela Messina, Rita Barone, ... Domenico Garozzo in Biomarkers for Alzheimer’s Disease Drug Development
    Protocol 2024
  10. Detection of Intracellular Complement Activation by Nanoparticles in Human T Lymphocytes

    The complement system is complex and includes two main components: the systemic or plasma complement and the so-called intracellular complement or...
    Anna Ilinskaya, Ankit Shah, ... Marina A. Dobrovolskaia in Characterization of Nanoparticles Intended for Drug Delivery
    Protocol 2024
  11. Detection of Induction of Mitochondrial Oxidative Stress by Nanoparticles in T Cells Using MitoSOX Red Dye

    The induction of oxidative stress by engineered nanomaterials has been associated with cytotoxic and inflammatory responses, damaging healthy cells...
    Ankit Shah, Marina A. Dobrovolskaia in Characterization of Nanoparticles Intended for Drug Delivery
    Protocol 2024
  12. Understanding the Role of Scavenger Receptor A1 in Nanoparticle Uptake by Murine Macrophages

    Nanoparticles can be cleared from the circulation and taken up by tissue-resident macrophages. This property can be beneficial when drug or antigen...
    Edward Cedrone, Martin Schuster, ... Marina A. Dobrovolskaia in Characterization of Nanoparticles Intended for Drug Delivery
    Protocol 2024
  13. Measuring Size and Number Concentration of Metallic Nanoparticles Using spICP-MS

    This protocol describes how to measure the size and concentration of individual metallic nanoparticles using inductively coupled plasma-mass...
    Matthew Hansen, Jeffrey D. Clogston in Characterization of Nanoparticles Intended for Drug Delivery
    Protocol 2024
  14. Methods for Analysis of Nanoparticle Immunosuppressive Properties

    Adverse drug effects on immune system function represent a significant concern in the pharmaceutical industry, because 10–20% of drug withdrawal from...
    Edward Cedrone, Timothy M. Potter, ... Marina A. Dobrovolskaia in Characterization of Nanoparticles Intended for Drug Delivery
    Protocol 2024
  15. Evaluation of the Acute Anaphylactoid Reactogenicity of Nanoparticle-Containing Medicines and Vaccines Using the Porcine CARPA Model

    A small fraction, up to 10%, of people treated intravenously with state-of-the-art nanoparticulate drugs or diagnostic agents develop an acute...
    Protocol 2024
  16. Immunophenoty**, Part I: Instrument Calibration and Reagent Qualification for Immunophenoty** Analysis of Human Peripheral Blood Mononuclear Cell Cultures

    Nanoparticles are increasingly used in biomedical applications to influence the way the immune system reacts to tumors and infectious disease-causing...
    Hannah S. Newton, Jenny Zhang, Marina A. Dobrovolskaia in Characterization of Nanoparticles Intended for Drug Delivery
    Protocol 2024
  17. Ion Quantitation in Liposomal Products Using RP-HPLC with Charged Aerosol Detection

    Ion concentration in liposomal drugs is important for drug stability and drug release profile. However, quantifying ion concentration in liposomal...
    Protocol 2024
  18. In Silico Models to Validate Novel Blood-Based Biomarkers

    Biological validation of preliminary findings is a key prerequisite in biomarker discovery. In recent years, the development of advanced large-scale...
    Protocol 2024
  19. Mass Spectrometry-Based Metabolomics Multi-platform for Alzheimer’s Disease Research

    The integration of complementary analytical platforms is nowadays the most common strategy for comprehensive metabolomics analysis of complex...
    Álvaro González-Domínguez, Ana Sayago, ... Raúl González-Domínguez in Biomarkers for Alzheimer’s Disease Drug Development
    Protocol 2024
  20. High-Throughput Lipidomic and Metabolomic Profiling for Brain Tissue and Biofluid Samples in Neurodegenerative Disorders

    Recent research has revealed the potential of lipidomics and metabolomics in identifying new biomarkers and mechanistic insights for...
    Bonne M. Thompson, Giuseppe Astarita in Biomarkers for Alzheimer’s Disease Drug Development
    Protocol 2024
Did you find what you were looking for? Share feedback.